[Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002908:Chronic Disease; D005260:Female; D005734:Gangrene / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000188:drug therapy; D013806:Theophylline / Q000627:therapeutic use*; D013919:Thromboangiitis Obliterans / Q000188:drug therapy
D009539:Nicotinic Acids; D013806:Theophylline
Azione emocinetica e metabolica del nicotinato di 7-2-(3-piridil-metilamino)-etil-teofillina, quale base della terapia medica delle arteriopatie croniche obliteranti periferiche.